Skip to main content
Contact Us
Subscribe
E-Edition
68°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Geron Corp
(NQ:
GERN
)
3.930
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Geron Corp
< Previous
1
2
3
4
5
Next >
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
April 01, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
March 30, 2022
From
Geron Corporation
Via
Business Wire
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
March 29, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 21, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Geron Corporation
Via
Business Wire
Geron to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Presentations at American Society of Hematology Annual Meeting
December 14, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Appointment of Chief Business Officer
December 02, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Geron Corporation
Via
Business Wire
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
November 12, 2021
From
Geron Corporation
Via
Business Wire
Geron Presents Investor Event Highlights
November 09, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
November 04, 2021
From
Geron Corporation
Via
Business Wire
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
October 25, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 18, 2021
From
Geron Corporation
Via
Business Wire
Geron to Host a Virtual Investor Event in November
October 15, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
October 11, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 16, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces September Investor Conference Presentation Webcasts
September 01, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 19, 2021
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
August 16, 2021
From
Geron Corporation
Via
Business Wire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
August 13, 2021
Via
FinancialNewsMedia
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
August 05, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 22, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
June 17, 2021
From
Geron Corporation
Via
Business Wire
Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress
June 14, 2021
From
Geron Corporation
Via
Business Wire
Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress
May 12, 2021
From
Geron Corporation
Via
Business Wire
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights
May 10, 2021
From
Geron Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.